Selected article for: "acute ards respiratory distress syndrome and lung possibly"
Author: Newton, Robert; Holden, Neil S.
Title: New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation
  • Cord-id: fquz3scq
  • Document date: 2006_3_20
    • ID: fquz3scq
    Snippet: Lung inflammation features in asthma, chronic obstructive airways disease (COPD), acute respiratory distress syndrome (ARDS), cystic fibrosis (CF) and others. Whilst in asthma anti-inflammatory glucocorticosteroids are generally effective, certain individuals are steroid resistant and in COPD, ARDS and CF, as well as disease exacerbations caused by infection, there seems little benefit. We summarise recent advances in p38 mitogen activated protein kinase (MAPK) biology and document beneficial an
    Document: Lung inflammation features in asthma, chronic obstructive airways disease (COPD), acute respiratory distress syndrome (ARDS), cystic fibrosis (CF) and others. Whilst in asthma anti-inflammatory glucocorticosteroids are generally effective, certain individuals are steroid resistant and in COPD, ARDS and CF, as well as disease exacerbations caused by infection, there seems little benefit. We summarise recent advances in p38 mitogen activated protein kinase (MAPK) biology and document beneficial and possibly detrimental effects in respect of lung inflammation.

    Search related documents:
    Co phrase search for related documents
    • activation expression and additional evidence: 1, 2
    • activation expression and lps challenge: 1
    • activation expression and lung oedema: 1
    • acute phase gene and additional evidence: 1
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long acting: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and lps challenge: 1
    • acute respiratory syndrome and lps induce: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and lps induce ards: 1, 2, 3, 4
    • acute respiratory syndrome and lung oedema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • additional evidence and long acting: 1